March 2, 2021
OncoBone has entered into an agency agreement with Guangdong Gucon Biotech Co. Ltd (“Gucon”). The agreement is exclusive, including Gucon to help OncoBone in finding new business in China.
Jussi Halleen, CEO of OncoBone comments: “I have known Gucon for more than 10 years and I am convinced that through their expertise and large network of potential customers of OncoBone, Gucon will be able to contribute extensively in expanding our business in China.”
Simon Guo, General Manager of Gucon adds: “Gucon is excited to work with OncoBone and has strong expectations for the collaboration. Gucon expects that especially the strong scientific expertise of OncoBone in oncology and bone biology will be attractive to our network”
If you are interested to learn more,
see our services or contact us directly.